Substituted imidazoquinolines
US9073913B2 · kind B2 · utility
2Cited by
4References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2009 |
| Grant date | Jul 7, 2015 |
| Priority date | — |
| Expiry date | Oct 29, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Imidazoquinolines of formula I that contain substituted amine or amide functionality at 1-position and that are effective as Toll like Receptor 7 activators are disclosed. These compounds are useful as anticancer agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.